On‑Site CRA II — Early-Phase Monitoring, Flexible & Remote

FTLEE Fortrea Clinical Research Unit Ltd; Leeds; Hybrid; GBP 35,000 - 52,000; Full time

Benefits offered by this job

Car allowance

Flexible working arrangements

Early-phase science exposure

Job summary

Fortrea Clinical Pharmacology Services Leeds is seeking a CRA II to monitor Phase I–Ib studies on-site at our Leeds CRU and selected UK sites. You will perform Pre-Study, Site Initiation, Routine Monitoring and Close-Out visits to ensure protocol compliance and data integrity.

Join a collaborative team with exposure to early-phase science, flexible working arrangements, and a competitive car allowance. You must be eligible to work in the UK and bring 2+ years of independent monitoring experience.

Qualifications

• Minimum 2 years independent site monitoring experience on Phase I–Ib trials.
• Knowledge of SAE reporting and follow-up processes.
• Life science degree or nursing qualification; eligible to work in the UK.

Responsibilities

• Monitor Phase I–Ib studies across Fortrea CRU and UK sites.
• Perform Pre-Study, Site Initiation, Routine Monitoring and Close-Out visits.
• Review source data, protocol compliance, and data quality using eSource and EDC.

Skills

Site monitoring

Independent monitoring experience

ICH GCP knowledge

Education

Life science degree

Nursing qualification

Tools

EDC systems

eSource

Job description

Fortrea Clinical Pharmacology Services Leeds is seeking a CRA II to monitor Phase I–Ib studies on-site at our Leeds CRU and selected UK sites. You will perform Pre-Study, Site Initiation, Routine Monitoring and Close-Out visits to ensure protocol compliance and data integrity.

Join a collaborative team with exposure to early-phase science, flexible working arrangements, and a competitive car allowance. You must be eligible to work in the UK and bring 2+ years of independent monitoring experience.